Home › Funds › BVF INC/IL › MLTX

BVF INC/IL position in MLTX

MOONLAKE IMMUNOTHERAPEUTICS · Health Care

BVF INC/IL reported holding 16,001,284 shares of MLTX (MOONLAKE IMMUNOTHERAPEUTICS) in its Q2 2026 13F filing — a position valued at US$311.5M, representing 7.97% of its reported portfolio and ranking #4 among its reported holdings. BVF INC/IL has disclosed MLTX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)16.00M sh
Reported value held$311.54M
Portfolio Weight7.97%
First reportedQ3 2023
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How BVF INC/IL's MLTX position evolved

BVF INC/IL first disclosed a stake in MLTX in Q3 2023 at 21,751,284 shares (US$1.24B). The position peaked in Q4 2023 at 21,751,284 shares, worth US$1.31B. Across 12 filings, BVF INC/IL increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 9 time(s). The most recent filing (Q2 2026) shows 16,001,284 shares valued at US$311.5M.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 21.75M $1.24B New
Q4 2023 21.75M $1.31B Hold
Q1 2024 21.75M $1.09B Hold
Q2 2024 21.75M $956.40M Hold
Q3 2024 21.75M $1.10B Hold
Q4 2024 19.75M $1.07B Reduce
Q1 2025 19.75M $771.68M Hold
Q2 2025 19.75M $932.26M Hold
Q3 2025 19.75M $141.62M Hold
Q4 2025 19.75M $260.32M Hold
Q1 2026 16.00M $298.26M Reduce
Q2 2026 16.00M $311.54M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MLTX and 13F data

MLTX (MOONLAKE IMMUNOTHERAPEUTICS) is a Health Care company. 29 other funds we track also report a position in MLTX — the largest reported positions include Deep Track Capital, LP (US$136.3M), Cormorant Asset Management, LP (US$62.4M), Logos Global Management LP (US$52.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MLTX

All MLTX fund holders →

FAQ

How long has BVF INC/IL held MLTX?

BVF INC/IL has disclosed MLTX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is BVF INC/IL's current position in MLTX?

As of Q2 2026, BVF INC/IL holds 16.00M shares of MLTX (MOONLAKE IMMUNOTHERAPEUTICS), valued at $311.54M, representing 7.97% of its reported portfolio and ranking #4.

Has BVF INC/IL been buying or selling MLTX?

In the latest 13F filing (Q2 2026), BVF INC/IL held unchanged its position in MLTX. The position peaked in Q4 2023 at 21.75M shares.

Which other funds hold MLTX?

Other major institutional holders of MLTX include Deep Track Capital, LP, Cormorant Asset Management, LP, Logos Global Management LP, among 29 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.